{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:43:03Z","timestamp":1786545783080,"version":"build-2736575974"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1038\/ajg.2009.629","type":"journal-article","created":{"date-parts":[[2009,11,10]],"date-time":"2009-11-10T10:59:21Z","timestamp":1257850761000},"page":"1039-1045","source":"Crossref","is-referenced-by-count":43,"title":["Elevated Serum Gastrin Is Associated With a History of Advanced Neoplasia in Barrett's Esophagus"],"prefix":"10.14309","volume":"105","author":[{"given":"Judy S","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Varro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles J","family":"Lightdale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nantaporn","family":"Lertkowit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen N","family":"Slack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L","family":"Fingerhood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei Yann","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy C","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian A","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210210","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1053\/j.gastro.2005.08.053","article-title":"Prevalence of Barretts esophagus in the general population: an endoscopic study.","volume":"129","author":"Ronkainen","year":"2005","journal-title":"Gastroenterology"},{"key":"R2-14-20210210","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1136\/gut.48.3.304","article-title":"Secular trends in the epidemiology and outcome of Barretts oesophagus in Olmsted County, Minnesota.","volume":"48","author":"Conio","year":"2001","journal-title":"Gut"},{"key":"R3-14-20210210","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/0016-5085(90)90607-3","article-title":"Prevalence of columnar-lined (Barretts) esophagus. Comparison of population-based clinical and autopsy findings.","volume":"99","author":"Cameron","year":"1990","journal-title":"Gastroenterology"},{"key":"R4-14-20210210","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/gut.2007.127878","article-title":"Role of obesity in GORD-related disorders.","volume":"57","author":"El-Serag","year":"2008","journal-title":"Gut"},{"key":"R5-14-20210210","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.295.13.1549","article-title":"Prevalence of overweight and obesity in the United States, 1999-2004.","volume":"295","author":"Ogden","year":"2006","journal-title":"JAMA"},{"key":"R6-14-20210210","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1365-2036.2007.03249.x","article-title":"Long-term treatment of patients with gastro-oesophageal reflux disease in routine care - results from the ProGERD study.","volume":"25","author":"Nocon","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"R7-14-20210210","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1001\/jama.287.15.1972","article-title":"Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review.","volume":"287","author":"Shaheen","year":"2002","journal-title":"JAMA"},{"key":"R8-14-20210210","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJM199903183401101","article-title":"Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.","volume":"340","author":"Lagergren","year":"1999","journal-title":"N Engl J Med"},{"key":"R9-14-20210210","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0016-5085(90)90946-X","article-title":"Effect of long-term treatment with omeprazole on serum gastrin and serum group A and C pepsinogens in patients with reflux esophagitis.","volume":"99","author":"Jansen","year":"1990","journal-title":"Gastroenterology"},{"key":"R10-14-20210210","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.canlet.2005.06.025","article-title":"Gastrin and cancer: a review.","volume":"238","author":"Ferrand","year":"2006","journal-title":"Cancer Lett"},{"key":"R11-14-20210210","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1053\/gast.2003.50091","article-title":"Gastrin induces proliferation in Barretts metaplasia through activation of the CCK2 receptor.","volume":"124","author":"Haigh","year":"2003","journal-title":"Gastroenterology"},{"key":"R12-14-20210210","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1158\/0008-5472.CAN-03-2713","article-title":"An antiapoptotic role for gastrin and the gastrinCCK-2 receptor in Barretts esophagus.","volume":"64","author":"Harris","year":"2004","journal-title":"Cancer Res"},{"key":"R13-14-20210210","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.regpep.2004.03.012","article-title":"Gastrin stimulates receptor-mediated proliferation of human esophageal adenocarcinoma cells.","volume":"120","author":"Moore","year":"2004","journal-title":"Regul Pept"},{"key":"R14-14-20210210","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.1158\/1078-0432.CCR-04-0015","article-title":"Gastrin-induced cyclooxygenase-2 expression in Barretts carcinogenesis.","volume":"10","author":"Abdalla","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R15-14-20210210","first-page":"990","article-title":"Cyclooxygenase-2 expression in the Barretts metaplasia-dysplasia-adenocarcinoma sequence.","volume":"96","author":"Morris","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R16-14-20210210","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000096593","article-title":"Hypergastrinemia is associated with increased risk of distal colon adenomas.","volume":"74","author":"Georgopoulos","year":"2006","journal-title":"Digestion"},{"key":"R17-14-20210210","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0016-5085(98)70193-3","article-title":"Gastrin and colorectal cancer: a prospective study.","volume":"115","author":"Thorburn","year":"1998","journal-title":"Gastroenterology"},{"key":"R18-14-20210210","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1517\/phgs.5.2.181.27483","article-title":"Pharmacogenomics of proton pump inhibitors.","volume":"5","author":"Furuta","year":"2004","journal-title":"Pharmacogenomics"},{"key":"R19-14-20210210","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1365-2362.1992.tb01423.x","article-title":"Increased tissue concentrations of the gastrin precursor in patients treated with omeprazole.","volume":"22","author":"Nemeth","year":"1992","journal-title":"Eur J Clin Invest"},{"key":"R20-14-20210210","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-2036.2008.03769.x","article-title":"Serum gastrin and pepsinogens do not correlate with the different grades of severity of gastro-oesophageal reflux disease: a matched case-control study.","volume":"28","author":"Monkemuller","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"R21-14-20210210","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1053\/j.gastro.2007.06.022","article-title":"Chronic proton pump inhibitor therapy and the risk of colorectal cancer.","volume":"133","author":"Yang","year":"2007","journal-title":"Gastroenterology"},{"key":"R22-14-20210210","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1053\/j.gastro.2007.06.014","article-title":"Proton pump inhibitor use and risk of colorectal cancer: a population-based, case-control study.","volume":"133","author":"Robertson","year":"2007","journal-title":"Gastroenterology"},{"key":"R23-14-20210210","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2036.2007.03579.x","article-title":"Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barretts oesophagus.","volume":"27","author":"Hillman","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"R24-14-20210210","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1111\/j.1572-0241.2004.30228.x","article-title":"Proton pump inhibitors are associated with reduced incidence of dysplasia in Barretts esophagus.","volume":"99","author":"El-Serag","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"R25-14-20210210","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1136\/gut.2005.086579","article-title":"Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK.","volume":"55","author":"Garcia Rodriguez","year":"2006","journal-title":"Gut"},{"key":"R26-14-20210210","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1053\/gast.1997.v112.pm9041231","article-title":"Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia.","volume":"112","author":"Eissele","year":"1997","journal-title":"Gastroenterology"},{"key":"R27-14-20210210","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1111\/j.1572-0241.2002.05902.x","article-title":"Hiatal hernia size, Barretts length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.","volume":"97","author":"Avidan","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"R28-14-20210210","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJM199510263331703","article-title":"A comparison of five maintenance therapies for reflux esophagitis.","volume":"333","author":"Vigneri","year":"1995","journal-title":"N Engl J Med"},{"key":"R29-14-20210210","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/0016-5085(94)90749-8","article-title":"Omeprazole vs. H2-receptor anta-gonists in treating patients with peptic stricture and esophagitis.","volume":"106","author":"Marks","year":"1994","journal-title":"Gastroenterology"},{"key":"R30-14-20210210","first-page":"G743","article-title":"Acid increases proliferation via ERK and p38 MAPK-mediated increases in cyclooxygenase-2 in Barretts adenocarcinoma cells.","volume":"287","author":"Souza","year":"2004","journal-title":"Am J Physiol"},{"key":"R31-14-20210210","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1053\/gast.2002.30993","article-title":"Acid exposure activates the mitogen-activated protein kinase pathways in Barretts esophagus.","volume":"122","author":"Souza","year":"2002","journal-title":"Gastroenterology"},{"key":"R32-14-20210210","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-230X-7-24","article-title":"Gene expression changes associated with Barretts esophagus and Barretts-associated adenocarcinoma cell lines after acid or bile salt exposure.","volume":"7","author":"Hao","year":"2007","journal-title":"BMC Gastroenterol"},{"key":"R33-14-20210210","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1572-0241.2004.04054.x","article-title":"In vitro acid exposure has a differential effect on apoptotic and proliferative pathways in a Barretts adenocarcinoma cell line.","volume":"99","author":"Morgan","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"R34-14-20210210","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1572-0241.2006.01005.x","article-title":"Acid has antiproliferative effects in nonneoplastic Barretts epithelial cells.","volume":"102","author":"Feagins","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"R35-14-20210210","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1158\/0008-5472.CAN-07-2023","article-title":"In non-neoplastic Barretts epithelial cells, acid exerts early antiproliferative effects through activation of the Chk2 pathway.","volume":"67","author":"Zhang","year":"2007","journal-title":"Cancer Res"},{"key":"R36-14-20210210","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1172\/JCI119018","article-title":"Dynamic effects of acid on Barretts esophagus. An ex vivo proliferation and differentiation model.","volume":"98","author":"Fitzgerald","year":"1996","journal-title":"J Clin Invest"},{"key":"R37-14-20210210","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1053\/gast.1999.0029900327","article-title":"Differentiation and proliferation in Barretts esophagus and the effects of acid suppression.","volume":"117","author":"Ouatu-Lascar","year":"1999","journal-title":"Gastroenterology"},{"key":"R38-14-20210210","doi-asserted-by":"crossref","first-page":"7987","DOI":"10.1038\/sj.onc.1204947","article-title":"Proton pump inhibitors reduce cell cycle abnormalities in Barretts esophagus.","volume":"20","author":"Umansky","year":"2001","journal-title":"Oncogene"},{"key":"R39-14-20210210","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1158\/1055-9965.EPI-05-0528","article-title":"Effect of acid suppression on molecular predictors for esophageal cancer.","volume":"15","author":"Lao-Sirieix","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R40-14-20210210","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0016-5085(00)70254-X","article-title":"Cyclooxygenase 2 expression in Barretts esophagus and adenocarcinoma: ex vivo induction by bile salts and acid exposure.","volume":"118","author":"Shirvani","year":"2000","journal-title":"Gastroenterology"},{"key":"R41-14-20210210","first-page":"2929","article-title":"Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barretts esophagus and associated adenocarcinomas.","volume":"58","author":"Wilson","year":"1998","journal-title":"Cancer Res"},{"key":"R42-14-20210210","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/j.1365-2036.2006.03119.x","article-title":"Systematic review: cyclo-oxygenase-2 in human oesophageal adenocarcinogenesis.","volume":"24","author":"Mehta","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"R43-14-20210210","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1053\/gast.2002.34244","article-title":"Rofecoxib inhibits cyclooxygenase 2 expression and activity and reduces cell proliferation in Barretts esophagus.","volume":"123","author":"Kaur","year":"2002","journal-title":"Gastroenterology"},{"key":"R44-14-20210210","first-page":"5767","article-title":"Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.","volume":"60","author":"Souza","year":"2000","journal-title":"Cancer Res"},{"key":"R45-14-20210210","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/jnci\/94.6.422","article-title":"The effect of selective cyclooxygenase-2 inhibition in Barretts esophagus epithelium: an in vitro study.","volume":"94","author":"Buttar","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"R46-14-20210210","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1053\/gast.2002.32371","article-title":"Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barretts esophagus.","volume":"122","author":"Buttar","year":"2002","journal-title":"Gastroenterology"},{"key":"R47-14-20210210","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1053\/j.gastro.2008.01.040","article-title":"Gastrin-mediated interleukin-8 and cyclooxygenase-2 gene expression: differential transcriptional and posttranscriptional mechanisms.","volume":"134","author":"Subramaniam","year":"2008","journal-title":"Gastroenterology"}],"updated-by":[{"DOI":"10.1038\/ajg.2009.723","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2010,2,5]],"date-time":"2010-02-05T00:00:00Z","timestamp":1265328000000}}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ajg2009629.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2009629","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2009629.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.ovid.com\/00000434-201005000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:46:28Z","timestamp":1786542388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201005000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1038\/ajg.2009.629","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}